Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Price to Sales HistoryFair Value
Percentile Rank71
3Y CAGR+26.1%
5Y CAGR-20.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+26.1%/yr
vs +68.5%/yr prior
5Y CAGR
-20.9%/yr
Recent acceleration
Acceleration
-42.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 316.73 | +4.6% |
| 2024 | 302.78 | +123.5% |
| 2023 | 135.50 | -14.3% |
| 2022 | 158.13 | -75.8% |
| 2021 | 653.40 | -36.3% |
| 2020 | 1026.07 | +3288.5% |
| 2019 | 30.28 | +54.5% |
| 2018 | 19.60 | -7.9% |
| 2017 | 21.29 | -87.2% |
| 2016 | 166.32 | - |